Cardiovascular Interviews ↓

Central Pressure And New Goals: Should Be Hypertension Therapy Priorities»
Bjorn Dahlof, Sahlgrenska University Hospital, Goteborg
A fundamental change in the way hypertension is measured, and studies to identify evidence-based blood pressure goals have been highlighted as top priorities by one of Sweden's prominent hypertension specialists, Björn Dahlöf, during the European Meeting on Hypertension.
Angiotensin AT2 Receptor Agonist: Restorative Role For Patients With Hypertension?»
Thomas Unger, Director, Institute of Pharmacology & Centre of Cardiovascular Research, Charité Medical University, Berlin
The illusive angiotensin AT2 receptor could become an important new target for therapy in the overall care of patients with hypertension. A leading researcher in cardiovascular medical science has found that by stimulating this receptor his group discovered remarkable regenerative and anti-inflammatory effects.

Click Here for All Cardiovascular Interviews

Oncology Interviews ↓

Colorectal Cancer: KRAS-Driven Selection Of Molecular Therapy Could Save Millions: Bevacizumab, Cetuximab, Panitumomab, or Combinations?

John S. Macdonald MD FACP

John S. Macdonald MD FACP

11th Annual Palm Beach Cancer Symposium (April 3-4, 2009 Hollywood, Florida)—Peter Goodwin interviews John Macdonald, Chief Medical Officer of Aptium Oncology in Los Angeles about his data on the relevance of KRAS tumor status to the choice of molecular therapy for patients with metastatic colorectal cancer. Whether the gene is wild-type or mutant determines sensitivity of the tumor to anti-epidermal growth factor or anti-vascular endothelial growth factor receptor therapy. Dr Macdonald also discusses the disappointing finding that blocking both of these proliferation pathways does not lead to improved efficacy when two targeted drugs are used in combination.

Chronic Myeloid Leukemia ‘To Become A Very Indolent Disease’: Pregnancy Possible, Transplants Avoided—Mission Accomplished?

Hagop Kantarjian MD

Hagop Kantarjian MD

11th Annual Palm Beach Cancer Symposium (April 3-4, 2009 Hollywood, Florida)—Peter Goodwin interviews Hagop Kantarjian MD from the MD Anderson Cancer Center in Houston about his latest findings on treating CML in patients who have the T315I mutation. He also discusses the feasibility of patients becoming pregnant while having tyrosine kinase inhibitor (TKI) treatment (among those who have achieved stability for at least two years); and talks about the decreased need for allogeneic transplant.

Global Health Interviews ↓

WHO-lead Report Urges Health Systems Priorities For Global Health Initiatives»
Peter Godfrey-Faussett, Professor of International Health and Infectious Diseases, London School of Hygiene and Tropical Medicine
The global health initiatives set up in the last decade to fight killer diseases like AIDS, TB and Malaria are not investing enough in efforts made locally in countries around the world to deliver health through effective health systems. That's the upshot of a report published in the Lancet led by the World Health Organization which criticizes the otherwise high-achieving programmes like the Global Fund, The President's Emergency Plan, and the Global Alliance for Vaccines and Immunization. One of the authors, Peter Godfrey-Faussett, talked with Peter Goodwin after speaking at a symposium on this held to discuss the Lancet report at the London School of Hygiene and Tropical Medicine.
WASHINGTON—International Global Health Conference Identifies Priorities For Poor Communities; Gates Award Endorses London School Of Hygiene And Tropical Medicine»
The poorest members of the global community—not necessarily geographically defined—are those who need to be targeted in healthcare development rather than countries labelled as "developing". Peter Goodwin hears the views of Hans Rosling of the Karonlinska Institute during the Annual International Conference on Global Health held in Washington DC. He also talks with the outgoing president of the Global Health Council (which hosts the conference), Nils Daulaire, with the London School of Hygiene's Director, Andy Haines, and alumni, James Hospedales, Ariella Bock, Cherie Carter and Khizer Husain about the relevance of their education in their work in global health all over the world, and about the significance of the Gates Award to the London School's Distance Learning programme and efforts to strengthen healthcare institutions.

Click Here for All Global Health Interviews
Subscribe to Audio Medica Podcast